Vor Biopharma (VOR) Retained Earnings (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Retained Earnings of -$1.4 billion for Q1 2026, down 180.42% year-over-year from $1.7 billion in Q1 2025, and down 3347904.88% quarter-over-quarter from $41000.0 in Q4 2025.
Vor Biopharma (VOR) Retained Earnings (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Retained Earnings for 7 consecutive years, with -$1.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 180.42% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 180.42% YoY), while the FY2025 annual figure was $41000.0, up 86.36% from the prior year.
- Retained Earnings slipped to -$1.4 billion in Q1 2026 per VOR's latest filing, from $41000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $41000.0 in Q4 2025 and bottomed at -$2.9 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$522.4 million across 5 years, with a median of -$222.2 million in 2022.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 100.01% — and 2025, when it slumped 2947185.71%.
- Vor Biopharma's Retained Earnings stood at -$222.2 million in 2022, then slumped by 53.04% to -$340.1 million in 2023, then jumped by 100.01% to $22000.0 in 2024, then jumped by 86.36% to $41000.0 in 2025, then plunged by 3347904.88% to -$1.4 billion in 2026.
- Business Quant data shows VOR's Retained Earnings at -$1.4 billion in Q1 2026, $41000.0 in Q4 2025, and -$2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | -1.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.44 Bn |
| Mar 31, 2026 | -1.37 Bn |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | -2.88 Bn |
| Jun 30, 2025 | -2.06 Bn |
| Mar 31, 2025 | -489.48 Mn |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -426.28 Mn |
| Jun 30, 2024 | -70,000.00 |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -340.08 Mn |
| Sep 30, 2023 | -313.82 Mn |
| Jun 30, 2023 | -436,000.00 |
| Mar 31, 2023 | -250.65 Mn |
| Dec 31, 2022 | -222.22 Mn |
| Sep 30, 2022 | -198.31 Mn |
| Jun 30, 2022 | -174.52 Mn |
| Mar 31, 2022 | -152.86 Mn |
| Dec 31, 2021 | -130.12 Mn |
| Sep 30, 2021 | -111.87 Mn |